MassARRAY® SARS-CoV-2 Variant Panel (RUO)

High-Throughput, Low-Cost, Detection and Differentiation of Key SARS-CoV-2 Variants

Laboratories require cost-effective, rapid solutions to track the key SARS-CoV-2 variants currently in circulation globally. While sequencing-based technologies are commonly used, they are highly complex, expensive and have a long turnaround time.

The MassARRAY® SARS-CoV-2 Variant Panel from Agena Bioscience® enables laboratories to overcome these challenges with a high throughput, low-cost and rapid assay for the detection of 36 unique genetic markers and differentiation of key SARS-CoV-2 variants.

Our panel contains assays for each of the 15 variants, targeting a total of 36 genetic markers!

Key Assay Features
  • GET ACCURATE DETECTION – Detect and differentiate 15 unique SARS-CoV-2 variants from the Wuhan lineage of SARS-CoV-2.
  • MAXIMIZE THROUGHPUT – Process up to hundreds or thousands of samples on a single instrument in a single workday.
  • SIMPLIFY INTERPRETATION – Clear identification of variants of concern without the need for extensive bioinformatics analysis.
  • SAVE TIME & MONEY – Low-cost reagents and automated results reporting save lab resources.

The MassARRAY SARS-CoV-2 Variant Panel is available for Research Use Only.

The assay panel sets are available in both 96 and 384 reaction formats to support varying sample throughput.

Panel Resources
Ordering Information
Product # of Samples Format Catalog #
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) (10x96)
480 96 13340
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) – CPM (10x96)
480 CPM-96 13340F
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) (10x384)
1920 384 13341
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) – CPM (10x384)
1920 CPM-384 13341D
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) (2x384)
384 384 13342
MassARRAY SARS-CoV-2 Variant Panel Set v3
(RUO) – CPM (2x384)
384 CPM-384 13342D

" We strive to consistently adapt and improve our testing services to respond to the dynamically changing needs in this crisis. The MassARRAY System puts us in the position to quickly and reliably test samples for the most relevant Corona variants.

– Dr. Bernhard Thiele

CEO, SEQ-IT

Request Information